Evotec and Dow AgroSciences, a wholly owned subsidiary of The Dow Chemical Company, have signed a cellular target profiling collaboration.
The collaboration will leverage Evotec's advanced chemical proteomics services for the development of compounds at Dow AgroSciences.
Evotec chief operating officer Dr Mario Polywka said, "This collaboration highlights the broad applicability of Evotec's industry leading chemical proteomics platform to determine cellular target affinities and mechanisms of action on a proteome wide level and in a native context."
Under the deal, Evotec will perform quantitative chemical proteomics services (Cellular Target Profiling) to de-convolute phenotypic screening results obtained by Dow.
Dow AgroSciences discovery global leader Dr William Kleschick said, "This collaboration enhances Discovery's technology tool-box to accelerate our efforts to deliver novel solutions to our customers around the world."
Financial details have not been revealed.
